Two-Point Rise in PSA Before Diagnosis Identifies Men at High-Risk for Prostate Cancer Death

Armen Hareyan's picture

Prostate Cancer

Physicians and researchers continue to study prostate-specific antigen, or PSA, to establish guidelines on how to most effectively use the biomarker to identify prostate cancer and its aggressiveness.

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.